Does the number of injections change how a drug works?
NCT ID NCT07743151
First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time
Summary
This early-stage trial is testing an investigational drug called MK-1406 in healthy adults. The goal is to compare what happens to the drug in the body when it's given as two injections versus three injections, and to check if it's safe and well-tolerated. Participants will receive the drug under the skin and be monitored for side effects, including reactions at the injection site.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MK-1406
- What this could lead to
- If successful, this study could help determine the best injection schedule for MK-1406, potentially leading to a more convenient or effective dosing regimen for future treatments.
- What could go wrong
- This is an early-phase trial focused on safety and drug processing, not on treating a disease. The results may not lead to a marketable treatment, and side effects like injection-site reactions are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test